MASSACESI, LUCA
MASSACESI, LUCA
Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)
7T MRI reveals the perivascular distribution of lesions in an animal model of multiple sclerosis
2011 Gaitan, MI; Maggi, P; Wohler, J; Sati, P; Silva, AC; Massacesi, L; Jacobson, S; Reich, DS
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients.
1998 A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study
2016 Montanari, E.; Rottoli, M.; Maimone, D.; Confalonieri, P.; Plewnia, K.; Frigo, M.; Francia, A.; Pala, A.; Losignore, N. A.; Ragonese, P.; Veneziano, A.; Traccis, S.; Bosco, G.; Dotta, M.; Severi, S.; Ragno, M.; Candeago, R. M.; Feleppa, M.; Stecchi, S.; Bosco, D.; Tola, M. R.; Massacesi, L.; Costantino, G.; Solaro, C. M.; Serrati, C.; Totaro, R.; Coniglio, M. G.; Scarpini, E.; Zuliani, C.; Perla, F.; Ticca, A.; Cottone, S.; Iudice, A.; Koudriavteva, T.; Di Battista, G.; Gasperini, C.; Perin, C.; Meola, G.; Pugliatti, M.; Bandini, F.; Cavalla, P.; Posteraro, F.; Consoli, D.
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet
2019 Pasca M.; Picchioni A.; Mazzeo S.; Terenzi F.; Prestipino E.; Fratangelo R.; Repice A.M.; Carlucci G.; Massacesi L.; Barilaro A.
A genome screen for multiple sclerosis in Italian families.
2001 BROADLEY S; SAWCER S; D'ALFONSO S; HENSIEK A; CORADDU F; GRAY J; ROXBURGH R; CLAYTON D; BUTTINELLI C; QUATTRONE A; TROJANO M; MASSACESI L; COMPSTON A;
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.
2007 ALDINUCCI A; GERLINI G; FOSSATI S; CIPRIANI G; BALLERINI C; BIAGIOLI T; PIMPINELLI N; BORGOGNONI L; MASSACESI L; MORONI F; CHIARUGI A.
A linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families.
1999 DALFONSO S; NISTIC L; ZAVATTARI P; MARROSU M; MURRU R; LAI M; L. MASSACESI; BALLERINI C; GESTRI D; SALVETTI M; RISTORI G; BOMPREZZI R; TROJANO M; LIGUORI M; GAMBI D; QUATTRONE A; FRUCI D; CUCCA F; MOMIGLIANO RICHIARDI P; TOSI R
A new primate model for multiple sclerosis in the common marmoset.
2000 'T HART B.A.; VAN MEURS M.; BROK H.P.M.; MASSACESI L; BAUER J.; BOON L.; BONTROP R.E.; LAMAN J.D.;
A sequence variation in the MOG gene is involved in Multiple Sclerosis susceptibility in Italy.
2008 DALFONSO S; BOLOGNESI E; GUERINI F; BARIZZONE N; BOCCA S; CASTELLI L; BERGAMASCHI L; AGLIARDI C; FERRANTE P; NALDI P; LEONE M; CAPUTO D; BALLERINI C; SALVETTI M; GALIMBERTI D; MASSACESI L; TROJANO M; MOMIGLIANO-RICHIARDI P; FERRANTE D.
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases
1999 Mazzucco, S; Matà, S; Vergelli, M; Fioresi, R; Nardi, E; Mazzanti, B; Chelli, M; Lolli, F; Ginanneschi, M; Pinto, F; Massacesi, L; Papini, A M
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases.
1999 MAZZUCCO S; MAT S; VERGELLI M; FIORESI R; NARDI E; MAZZANTI B; CHELLI M; LOLLI F; GINANNESCHI M; PINTO F; L. MASSACESI; PAPINI A.M
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population.
2003 LIGUORI M; SAWCER S; SETAKIS E; COMPSTON A; GIORDANO M; D'ALFONSO S; MELLAI M; MALFERRARI G; TROJANO M; LIVREA P; DE ROBERTIS F; MASSACESI L; REPICE A; BALLERINI C; BIAGIOLI T; BOMPREZZI R; CANNONI S; RISTORI G; SALVETTI M; GRIMALDI L.M; BIUNNO I; COMI G; LEONE M; FERRO I; NALDI P; MILANESE C; GELLERA C; LOREDANA L.M; SAVETTIERI G; SALEMI G; ARIDON P; CAPUTO D; ROSA GUERINI F; FERRANTE P; MOMIGLIANO-RICHIARDI P;
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis.
2017 M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L.
Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
1995 L. MASSACESI; GENAIN C.P; PARRITZ D.L; CANFIELD D; LETVIN N. AND HAUSER S.L
Alemtuzumab improves outcomes in RRMS patients who switched from SC IFNB-1a: 6-year follow-up of CARE-MS I Patients (TOPAZ Study)
2019 Montalban, X; Barone, D; Broadley, S; Dive, D; Hupperts, RM; Lycke, J; Massacesi, L; Naismith, RT; Nakamura, K; Pandey, K; Schippling, S; Vermersch, P; Wiendl, H; Chung, L; Daizadeh, N; Afsar, S; Van Wijmeersch, B
Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study)
2018 Van Wijmeersch, B; Barone, D; Broadley, S; Dive, D; Hupperts, RMM; Lycke, J; Massacesi, L; Montalban, X; Naismith, RT; Pandey, K; Schippling, S; Vermersch, P; Chung, L; Daizadeh, N; Rodriguez, CE; Nakamura, K; Wiendl, H
An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population.
2000 D'Alfonso S; Nisticò L; Bocchio D; Bomprezzi R; Marrosu MG; Murru MR; Lai M; Massacesi L; Ballerini C; Repice A; Salvetti M; Montesperelli C; Ristori G; Trojano M; Liguori M; Gambi D; Quattrone A; Tosi R; Momigliano-Richiardi P.
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC.
2013 Simone Giannecchini ; Irene Giovannelli; Valeria Clausi; Anna Repice; Luca Massacesi; Alberta Azzi
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
2022 Mariottini A, Repice AM, Barilaro A, Massacesi L
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis.
1993 LOLLI F; LIUZZI G.M; VERGELLI M; L. MASSACESI; BALLERINI C; AMADUCCI L; RICCIO P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 7T MRI reveals the perivascular distribution of lesions in an animal model of multiple sclerosis | 2011 | Gaitan, MI; Maggi, P; Wohler, J; Sati, P; Silva, AC; Massacesi, L; Jacobson, S; Reich, DS | |
| [Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients. | 1998 | A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI | |
| A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study | 2016 | Montanari, E.; Rottoli, M.; Maimone, D.; Confalonieri, P.; Plewnia, K.; Frigo, M.; Francia, A.; Pala, A.; Losignore, N. A.; Ragonese, P.; Veneziano, A.; Traccis, S.; Bosco, G.; Dotta, M.; Severi, S.; Ragno, M.; Candeago, R. M.; Feleppa, M.; Stecchi, S.; Bosco, D.; Tola, M. R.; Massacesi, L.; Costantino, G.; Solaro, C. M.; Serrati, C.; Totaro, R.; Coniglio, M. G.; Scarpini, E.; Zuliani, C.; Perla, F.; Ticca, A.; Cottone, S.; Iudice, A.; Koudriavteva, T.; Di Battista, G.; Gasperini, C.; Perin, C.; Meola, G.; Pugliatti, M.; Bandini, F.; Cavalla, P.; Posteraro, F.; Consoli, D. | |
| A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet | 2019 | Pasca M.; Picchioni A.; Mazzeo S.; Terenzi F.; Prestipino E.; Fratangelo R.; Repice A.M.; Carlucci G.; Massacesi L.; Barilaro A. | |
| A genome screen for multiple sclerosis in Italian families. | 2001 | BROADLEY S; SAWCER S; D'ALFONSO S; HENSIEK A; CORADDU F; GRAY J; ROXBURGH R; CLAYTON D; BUTTINELLI C; QUATTRONE A; TROJANO M; MASSACESI L; COMPSTON A; | |
| A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation. | 2007 | ALDINUCCI A; GERLINI G; FOSSATI S; CIPRIANI G; BALLERINI C; BIAGIOLI T; PIMPINELLI N; BORGOGNONI L; MASSACESI L; MORONI F; CHIARUGI A. | |
| A linkage analysis of Multiple Sclerosis with candidate region markers in Sardinian and Continental Italian families. | 1999 | DALFONSO S; NISTIC L; ZAVATTARI P; MARROSU M; MURRU R; LAI M; L. MASSACESI; BALLERINI C; GESTRI D; SALVETTI M; RISTORI G; BOMPREZZI R; TROJANO M; LIGUORI M; GAMBI D; QUATTRONE A; FRUCI D; CUCCA F; MOMIGLIANO RICHIARDI P; TOSI R | |
| A new primate model for multiple sclerosis in the common marmoset. | 2000 | 'T HART B.A.; VAN MEURS M.; BROK H.P.M.; MASSACESI L; BAUER J.; BOON L.; BONTROP R.E.; LAMAN J.D.; | |
| A sequence variation in the MOG gene is involved in Multiple Sclerosis susceptibility in Italy. | 2008 | DALFONSO S; BOLOGNESI E; GUERINI F; BARIZZONE N; BOCCA S; CASTELLI L; BERGAMASCHI L; AGLIARDI C; FERRANTE P; NALDI P; LEONE M; CAPUTO D; BALLERINI C; SALVETTI M; GALIMBERTI D; MASSACESI L; TROJANO M; MOMIGLIANO-RICHIARDI P; FERRANTE D. | |
| A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases | 1999 | Mazzucco, S; Matà, S; Vergelli, M; Fioresi, R; Nardi, E; Mazzanti, B; Chelli, M; Lolli, F; Ginanneschi, M; Pinto, F; Massacesi, L; Papini, A M | |
| A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. | 1999 | MAZZUCCO S; MAT S; VERGELLI M; FIORESI R; NARDI E; MAZZANTI B; CHELLI M; LOLLI F; GINANNESCHI M; PINTO F; L. MASSACESI; PAPINI A.M | |
| A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. | 2003 | LIGUORI M; SAWCER S; SETAKIS E; COMPSTON A; GIORDANO M; D'ALFONSO S; MELLAI M; MALFERRARI G; TROJANO M; LIVREA P; DE ROBERTIS F; MASSACESI L; REPICE A; BALLERINI C; BIAGIOLI T; BOMPREZZI R; CANNONI S; RISTORI G; SALVETTI M; GRIMALDI L.M; BIUNNO I; COMI G; LEONE M; FERRO I; NALDI P; MILANESE C; GELLERA C; LOREDANA L.M; SAVETTIERI G; SALEMI G; ARIDON P; CAPUTO D; ROSA GUERINI F; FERRANTE P; MOMIGLIANO-RICHIARDI P; | |
| Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. | 2017 | M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L. | |
| Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. | 1995 | L. MASSACESI; GENAIN C.P; PARRITZ D.L; CANFIELD D; LETVIN N. AND HAUSER S.L | |
| Alemtuzumab improves outcomes in RRMS patients who switched from SC IFNB-1a: 6-year follow-up of CARE-MS I Patients (TOPAZ Study) | 2019 | Montalban, X; Barone, D; Broadley, S; Dive, D; Hupperts, RM; Lycke, J; Massacesi, L; Naismith, RT; Nakamura, K; Pandey, K; Schippling, S; Vermersch, P; Wiendl, H; Chung, L; Daizadeh, N; Afsar, S; Van Wijmeersch, B | |
| Alemtuzumab outcomes over 6 years in RRMS patients who switched from SC IFNB-1a: follow-up of CARE-MS I patients (TOPAZ study) | 2018 | Van Wijmeersch, B; Barone, D; Broadley, S; Dive, D; Hupperts, RMM; Lycke, J; Massacesi, L; Montalban, X; Naismith, RT; Pandey, K; Schippling, S; Vermersch, P; Chung, L; Daizadeh, N; Rodriguez, CE; Nakamura, K; Wiendl, H | |
| An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population. | 2000 | D'Alfonso S; Nisticò L; Bocchio D; Bomprezzi R; Marrosu MG; Murru MR; Lai M; Massacesi L; Ballerini C; Repice A; Salvetti M; Montesperelli C; Ristori G; Trojano M; Liguori M; Gambi D; Quattrone A; Tosi R; Momigliano-Richiardi P. | |
| Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. | 2013 | Simone Giannecchini ; Irene Giovannelli; Valeria Clausi; Anna Repice; Luca Massacesi; Alberta Azzi | |
| Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance | 2022 | Mariottini A, Repice AM, Barilaro A, Massacesi L | |
| Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis. | 1993 | LOLLI F; LIUZZI G.M; VERGELLI M; L. MASSACESI; BALLERINI C; AMADUCCI L; RICCIO P |